| Site | Procedure | Radiopharmaceutical | Dose by Weight | Adult (70kg) | Minimum | Maximum |
| Bone | Whole body | Tc-99m MDP | 0.360 mCi/kg | 25 mCi | 3 mCi | |
| Bone | Limited & 3-Phase | Tc-99m MDP | 0.360 mCi/kg | 25 mCi | 3 mCi | 32 mCi |
| Bone | 3-Phase Bone PEDS (planar) | Tc-99m MDP | 0.360 mCi/kg | 25 mCi | 1 mCi | |
| Bone | 3-Phase Bone PEDS (SPECT) | Tc-99m MDP | 0.360 mCi/kg | 25 mCi | 2 mCi | |
| Bone | SPECT | Tc-99m MDP | 0.360 mCi/kg | 25 mCi | 3 mCi | |
| Bone | Bone Marrow | Tc-99m Sulfur Colloid | 0.143 m Ci/kg | 10 mCi | 0.500 mCi | |
| Brain | Perfusion | Tc-99m Neurolite (Bicisate ECD) | 0.430 mCi/kg | 30 mCi | 5 mCi | |
| Brain | Perfusion | Tc-99m Ceretec (HMPAO) | 0.430 mCi/kg | 30 mCi | 5 mCi | |
| Brain | Brain Death | Tc-99m Neurolite (Bicisate ECD) | 0.430 mCi/kg | 30 mCi | 5 mCi | |
| Brain | Brain Death | Tc-99m Ceretec (HMPAO) | 0.430 mCi/kg | 30 mCi | 5 mCi | |
| Brain | Tumor | Tl-201 Thallium | 0.057 mCi/kg | 4 mCi | 5 mCi | |
| Brain | Tumor | Tc-99m Sestamibi | 0.357 mCi/kg | 25 mCi | 5 mCi | |
| Cardiac | Myocardial REST | Tc-99m Sestamibi/Tetrafosmin | 0.114 mCi/kg | 8 mCi | 8 mCi | 15 mCi |
| Cardiac | Myocardial STRESS | Tc-99m Sestamibi/Tetrafosmin | 0.357 mCi/kg | 25 mCi | 25 mCi | 45 mCi |
| Cardiac | Myocardial REST | Tl-201 Thallium | 0.043 mCi/kg | 3 mCi | ||
| Cardiac | Myocardial STRESS | Tl-201 Thallium | 0.043 mCi/kg | 3 mCi | ||
| Cardiac | Myocardial Redistribution | Tl-201 Thallium | 0.043 mCi/kg | 3 mCi | ||
| Cardiac | Reinjection | Tl-201 Thallium | 0.014 mCi/kg | 1 mCi | ||
| Cardiac | Myocardial Infarct Imaging | Tc-99m Pyrophosphates | 0.285 mCi/kg | 20 mCi | ||
| Cardiac | MUGA | Tc-99m RBC | 0.285 mCi/kg | 30 mCi | 5 mCi | 30 mCi |
| CNS | Cisternogram | In-111 DTPA | 0.007 mCi/kg | 0.500 mCi | 0.200 mCi | |
| CNS | CSF Leak | In-111 DTPA | 0.007 mCi/kg | 0.500 mCi | 0.200 mCi | |
| CNS | Shunt Studies (VP & LP) | In-111 DTPA | 0.007 mCi/kg | 0.500 mCi | 0.200 mCi | |
| Endocrine | Adrenal | I-131 Iodocholesterol (NP-59) | 0.014 mCi/kg | 1.0 mCi | ||
| Endocrine | Kidney Localizer | Tc-99m DTPA or MAG 3 | 0.500 mCi | |||
| Endocrine | Parathyroid | Tc-99m Sestamibi | 22 mCi | |||
| Endocrine | Parathyroid/Dual | Tc-99m & Tl-201 | 2 mCi each | |||
| Endocrine | Thyroid Uptake & Scan | I-123 Sodium iodide cap (PO) | 0.200 mCi | 0.050-0.10 mCi | ||
| Endocrine | Thyroid Uptake & Scan | Tc-99m | 6 mCi | |||
| Endocrine | Thyroid Uptake only | I-123 Sodium iodide cap (PO) | 0.200 mCi | 0.050-0.10 mCi | ||
| Endocrine | Total Body Scan (low iodine diet) | I-131 Sodium iodide (PO) | 3 mCi | |||
| Endocrine | Total Body Scan (with rhTSH) | I-131 Sodium iodide (PO) | 4 mCi | |||
| Endocrine | Total Body Scan | I-123 Sodium iodide (PO) | 1.5 mCi | |||
| Endocrine | Therapeutic (Rx) | I-131 (Dose determined by MD) | 5-200 mCi | |||
| Gastrointestinal | Liver-Spleen (SPECT) | Tc-99m Sulfur Colloid | 0.090 mCi/kg | 6 mCi | 0.500 mCi | |
| Gastrointestinal | Liver-Spleen (Planar) | Tc-99m Sulfur Colloid | 0.090 mCi/kg | 6 mCi | 0.500 mCi | |
| Gastrointestinal | RBC Liver | Tc-99m RBC | 0.290 mCi/kg | 20 mCi | 3 mCi | |
| Gastrointestinal | HIDA, Standard | Tc-99m HIDA (Choletech) | 0.100 mCi/kg | 5 mCi | 2 mCi | |
| Gastrointestinal | HIDA, Transplant | Tc-99m HIDA (Choletech) | 0.100 mCi/kg | 5 mCi | 2 mCi | |
| Gastrointestinal | HIDA, Dynamic | Tc-99m HIDA (Choletech) | 0.100 mCi/kg | 5 mCi | 2 mCi | |
| Gastrointestinal | Gastric Emptying | Tc-99m Sulfur Colloid | 0.0143 mCi/kg | 1 mCi | 0.250-1.0 mCi | |
| Gastrointestinal | GI Bleed | Tc-99m RBC | 0.285 mCi/kg | 20 mCi | 3 mCi | |
| Gastrointestinal | GI Bleed | Tc-99m Sulfur Colloid | 6 mCi | |||
| Gastrointestinal | Meckels Diverticulum | Tc-99m Pertechnetate | 0.142 mCi/kg | 10 mCi | 1 mCi | |
| Gastrointestinal | Intrahepatic Pump Patency | Tc-99m MAA (infra-pump) | 3 mCi | |||
| Gastrointestinal | Leveen/Denver Shunt | Tc-99m MAA (intraperitoneal) | 4 mCi | 0.050 mCi | ||
| Hematology | Plasma Volume | I-125 albumin | 0.005-0.010 mCi | |||
| Hematology | Red Cell Mass | Cr-51 RBC (Sodium Chromate) | 0.002 mCi/kg | 0.150 mCi | ||
| Hematology | Red Blood Cell Survival | Cr-51 (Sodium Chromate) | 0.150 mCi | |||
| Infection | Abdominal/Extremities | In-111 Oxine labeled WBC | 0.007 mCi/kg | 0.500 mCi | 0.050 mCi | |
| Infection | Abdominal/Extremities | Tc-99m HMPAO labeled WBC | 0.268 mCi/kg | 20 mCi | ||
| Infection | Abdominal/Extremities | Ga-67 Gallium Citrate | 0.090 mCi/kg | 6 mCi | 1 mCi | |
| Infection | Lung | Ga-67 Gallium Citrate | 0.090 mCi/kg | 6 mCi | 1 mCi | |
| Lung | Perfusion (V/Q) | Tc-99m MAA | 0.017 mCi/kg | 1.5 mCi | 0.200 mCi | |
| Lung | Ventilation (V/Q) | Tc-99m DTPA (aerolized) | 6 mCi | 1 mCi | ||
| Lung | Perfusion (V/Q) | Tc-99m MAA | 5 mCi | |||
| Lung | Ventilation (V/Q) | Xe-133 | 10 mCi | |||
| Lung | Quantitative | Tc-99m MAA | 0.017 mCi/kg | 1.5 mCi | 0.200 mCi | |
| Lung | Right to left Shunt | Tc-99m MAA | 0.017 mCi/kg | 1.2 mCi | 0.200 mCi | |
| Renal | Standard & Transplant | Tc-99m MAG 3 | 0.142 mCi/kg | 10 mCi | 3 mCi | |
| Renal | Standard & Transplant | Tc-99m DTPA | 0.142 mCi/kg | 10 mCi | 3 mCi | |
| Renal | Static Renal (Parenchymal) | Tc-99m DMSA | 0.029 mCi/kg | 2 mCi | 0.500 mCi | |
| Renal | Testicular | Tc-99m Pertechnetate | 0.290 mCi/kg | 20 mCi | 5 mCi | |
| Renal | VCUG | Tc-99m DTPA | 0.140 mCi/kg | I mCi | ||
| Renal | GFR | I-125 Sodium Iothalamate (Glofil) | 0.03 mCi | |||
| Renal | GFR | Tc-99m DTPA | 0.014 mCi/kg | 1.000 mCi | 0.100 mCi | |
| Renal | GFR | In-111 DTPA | 0.003 mCi/kg | |||
| Therapeutic | Strontium Therapy | Strontium-89 | 4.0 mCi | |||
| Therapeutic | Samarium (Quadramet) Tx | Samarium-153 Lexidronam | 1.0 mCi/kg | |||
| Therapeutic | P-32 Therapy | P-32 (Sodium Phosphate) | 2.3 mCi / sq m | max 7.0 mCi | ||
| Therapeutic | I-131 Rx R | I-131 Capsules or Oral Solution | 5-200 mCi | |||
| Tumor | Whole Body | Tc-99m Sestamibi | 0.314 mCi/kg | 22 mCi | ||
| Tumor | Whole Body | Ga-67 Gallium Citrate | 0.143 mCi/kg | 10 mCi | 1 mCi | |
| Tumor | Whole Body | Tl-201 Thallium | 0.057 mCi/kg | 4 mCi | ||
| Tumor | Whole Body | In-111 Octreotide | 0.085 mCi/kg | 6 mCi | ||
| Tumor | Whole Body | In-111 Oncoscint | 0.071 mCi/kg | 5 mCi | ||
| Tumor | Whole Body | I-131 MIBG | 0.007 mCi/kg | 0.500 mCi | 0.100 mCi | |
| Tumor | Whole Body | Tc-99m Arcitumomab (CEA-Scan) | 0.429 mCi/kg | 30.0 mCi | ||
| Tumor | Prostascint Scan | In-111 Capromab Pendetide | 5.0 mCi | |||
| Tumor | Lymph drain (melanoma) | Tc-99m Sulfur Colloid (Filtered) | 0.500 mCi | |||
| Tumor | Lymphatic flow (lymphadema) | Tc-99m Sulfur Colloid (Filtered) | 0.500 mCi / extremity | |||
| Tumor | Breast Imaging( 2 day) | Tc-99m Sulfur Colloid (Unfiltered) | 2.0 mCi | |||
| Tumor | Breast Imaging (1 day) | Tc-99m Sulfur Colloid (Unfiltered) | 1.0 mCi | |||
| Venography | Lower Extremity | Tc-99m MAA (dorsum injection) | 0.500 mCi / foot | |||
| Venography | Upper Extremity | Tc-99m DTPA | 0.500 mCi / hand | |||
| PET WHOLE BODY | Whole Body | 18-F FDG | 0.21 mCi/kg | 15 mCi | ||
| PET WHOLE BODY | Whole Body | 18-F DOPA | 0.21 mCi/kg | 15 mCi | ||
| PET NEURO | Standard Brain (3D) | 18-F FDG | 0.14 mCi/kg | 10 mCi | ||
| PET NEURO | Parkinsons Dx | 18-F DOPA | 0.14 mCi/kg | 10 mCi | ||
| PET NEURO | Brain Tumor | 18-F DOPA | 0.07 mCi/kg | 3.5 mCi | ||
| PET NEURO | Brain Flow (3D) | 15-O H2O | (see attending) | 30 mCi | ||
| PET NEURO | Oxygen Extraction | 15-O O2 | (see attending) | 30 mCi | ||
| PET CARDIAC | Cardiac Flow (Rest and Stress) | 13-N NH3 | 0.30 mCi/kg | 30 mCi | ||
| PET CARDIAC | Cardiac Viability | 18-F FDG | 0.14 mCi/kg | 10 mCi | ||
| Pharmacological Drugs | Cardiovascular | Adenosine IV | 0.140 mg/kg/min x 4 min | |||
| Pharmacological Drugs | Cardiovascular | Persantine (Dypridinole) IV | 0.56 mg/kg x 4min | |||
| Pharmacological Drugs | Cardiovascular | Dobutamine | 250 mg infused per protocol | |||
| Pharmacological Drugs | Gastrointestinal | CCK (cholecystokinin/Kinevac) IV | 0.02 ug/kg | |||
| Pharmacological Drugs | Gastrointestinal | Morphine IV | 0.04 mg/kg | |||
| Pharmacological Drugs | Renal | Captopril (Capoten) PO | 25-50 mg | |||
| Pharmacological Drugs | Renal | Lasix (furosimide) IV | 0.3-0.5 mg/kg | |||
| Pharmacological Drugs | I-131 Therapeutic | Compazine PO | 10 mg/ tablet |